Cargando…
A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas
BACKGROUND: It is mandatory to confirm the absence of mutations in the KRAS gene before treating metastatic colorectal cancers with epidermal growth factor receptor inhibitors, and similar regulations are being considered for non-small cell lung carcinomas (NSCLC) and other tumor types. Routine diag...
Autores principales: | Jancik, Sylwia, Drabek, Jiri, Berkovcova, Jitka, Xu, Yong Zhong, Stankova, Marcela, Klein, Jiri, Kolek, Vitezslav, Skarda, Josef, Tichy, Tomas, Grygarkova, Ivona, Radzioch, Danuta, Hajduch, Marian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542008/ https://www.ncbi.nlm.nih.gov/pubmed/22995035 http://dx.doi.org/10.1186/1756-9966-31-79 |
Ejemplares similares
-
Clinical Relevance of KRAS in Human Cancers
por: Jančík, Sylwia, et al.
Publicado: (2010) -
Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbine
por: Gachechiladze, Mariam, et al.
Publicado: (2019) -
Carboplatin with intravenous and subsequent oral administration of vinorelbine in resected non-small-cell-lung cancer in real-world set-up
por: Kolek, Vítězslav, et al.
Publicado: (2017) -
Overexpression of PtDXS Enhances Stress Resistance in Poplars
por: Wei, Hui, et al.
Publicado: (2019) -
Performance of pyrosequencing versus MALDI-TOF MS in bacteria identification in chronic lung disease
por: Navrátilová, Lucie, et al.
Publicado: (2016)